Skip to main content

Bard IVC Lawsuits: Remand Order Suggestion Issued

Bard IVC Lawsuits: Remand Order Suggestion Issued

Bard IVC Lawsuits: Remand Order Suggestion Issued

Introduction

U.S. District Judge David G. Campbell determined about 600 Bard IVC filter cases are ready to be returned to different federal district courts nationwide for individual trial dates.

According to the Suggestion of Remand and Court Order (PDF) issued on August 20, the cases are being remanded as thousands of cases pending in the MDL have settled or are near a settlement, and the remaining cases would no longer benefit from centralized proceedings.

The U.S. Judicial Panel on Multidistrict Litigation (JPML) will now take into account to remand unresolved claims, and the cases are expected to be reassigned to various individual judges to set trial dates if agreements are not reached by the parties to settle the cases.

An Inferior vena cava filter (IVC filter), earlier popularly known as Greenfield filter, is a medical device implanted in the inferior vena cava just below the kidneys to capture blood clots, preventing them from reaching the heart and lungs, thereby, safeguarding against life-threatening pulmonary emboli (PE). IVC filters were cleared for use through the 510(k) process since 1976. However, in 2010 the FDA issued a device safety communication after reviewing more than 900 adverse events related to the devices over a period of five-years.

More than 8,000 product liability lawsuits were filed against C.R. Bard, consolidated under MDL No. 2641 presided by U.S. District Judge David G. Campbell. Each lawsuit had similar allegations that plaintiffs suffered pain and potential complications when the small devices moved out of position, penetrated internal organs, or fractured, causing small pieces to travel throughout the body.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!